West Wealth Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $358K | Sell |
1,823
-60
| -3% | -$11.8K | 0.09% | 74 |
|
2025
Q1 | $389K | Buy |
1,883
+38
| +2% | +$7.84K | 0.11% | 61 |
|
2024
Q4 | $328K | Buy |
1,845
+330
| +22% | +$58.7K | 0.1% | 66 |
|
2024
Q3 | $299K | Buy |
1,515
+9
| +0.6% | +$1.78K | 0.1% | 63 |
|
2024
Q2 | $258K | Buy |
1,506
+9
| +0.6% | +$1.54K | 0.09% | 70 |
|
2024
Q1 | $273K | Buy |
1,497
+9
| +0.6% | +$1.64K | 0.1% | 66 |
|
2023
Q4 | $231K | Sell |
1,488
-2
| -0.1% | -$310 | 0.09% | 75 |
|
2023
Q3 | $222K | Buy |
+1,490
| New | +$222K | 0.1% | 66 |
|
2023
Q2 | – | Sell |
-1,557
| Closed | -$248K | – | 75 |
|
2023
Q1 | $248K | Sell |
1,557
-452
| -22% | -$72K | 0.11% | 53 |
|
2022
Q4 | $325K | Buy |
2,009
+22
| +1% | +$3.56K | 0.16% | 47 |
|
2022
Q3 | $266K | Buy |
1,987
+29
| +1% | +$3.88K | 0.13% | 49 |
|
2022
Q2 | $299K | Buy |
1,958
+13
| +0.7% | +$1.99K | 0.14% | 47 |
|
2022
Q1 | $315K | Buy |
1,945
+6
| +0.3% | +$972 | 0.13% | 44 |
|
2021
Q4 | $262K | Buy |
+1,939
| New | +$262K | 0.1% | 46 |
|